Monopar Therapeutics: CFO Vu Quan Anh received 614 shares

What happened

• Vu Quan Anh, chief financial officer, had restricted stock units vest and received 614 shares on Sep 30, 2026. The filing also reports 180 shares were withheld to cover withholding tax for $14,341, and a related derivative conversion entry for 614 shares at $0.00.

Key details

• Transactions reported on Sep 30, 2026:
  • Exercise/conversion of derivative (code M): 614 shares acquired; price reported as N/A; value N/A.
  • Payment of exercise price or tax liability (code F): 180 shares disposed at $79.67 for $14,341.
  • Exercise/conversion of derivative (code M): 614 shares disposed at $0.00 for $0 (derivative).
• Shares owned following the reported transaction: not reported in the provided filing.
• Relevant footnotes from the filing:
  • F1: Shares acquired on vesting and settlement of restricted stock units.
  • F2: Shares withheld by the issuer to pay applicable withholding tax upon vesting.
  • F3: The RSU grant (9,826 RSUs) vests on a schedule; disposed RSUs were surrendered in exchange for issuance of common stock upon vesting and settlement.
• The provided filing does not indicate a late filing.

Why it may matter

• The filing shows RSUs vested and shares were issued, with a portion withheld to satisfy withholding tax; this withholding is not a market sale by the insider.
• A filing does not show why the insider traded or why the company acted.